Professional Design Rapid Molecular Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis
Professional Design Rapid Molecular Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis Detail:
Introduction
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. SARSCoV-2, influenza A and influenza B viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Influenza virus belongs to the family of Orthomyxoviridae, and immunologically diverse, single-stranded RNA viruses. There influenza A and B virus is the main pathogen that severe illnesses both in human and in many animal species. Based on the current epidemiological investigation, the incubation period is 1 to 4 days. The main manifestations include acute fever, general aching and respiratory symptoms. Both Type A and B viruses can circulate simultaneously, but usually one type is dominant during a given season.1
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Detection
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens.
Specimen
Nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 74.8 TCID50/mL
Influenza A
Influenza Viral Strain |
Calculated |
A/New Caledonia/20/1999_H1N1 |
8.50×103 |
A/California/04/2009_H1N1 |
2.11×103 |
A/PR/8/34_H1N1 |
2.93×103 |
A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 |
4.94×102 |
A/Guizhou/54/89_H3N2 |
3.95×102 |
A/Human/Hubei/3/2005_H3N2 |
2.93×104 |
A/Bar-headed Goose/QH/BTY2/2015_H5N1 |
1.98×105 |
A/Anhui/1/2013_H7N9 |
7.90×105 |
Influenza B.
Influenza Viral Strain |
Calculated |
B/Victoria |
4.25×103 |
B/Yamagata |
1.58×102 |
Accuracy
Influenza A
Relative Sensitivity : 86.8%
Relative Specificity: 94%
Accuracy: 92.2%
Influenza B
Relative Sensitivity: 91.7%
Relative Specificity: 97.5%
Accuracy: 96.1%
COVID-19
Relative Sensitivity: 96.6%
Relative Specificity: 100%
Accuracy: 98.9%
Time to results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
Test devices | 20 tests |
Sterilized swabs | 20 pcs |
Extraction tubes (with 0.5mL extraction | 20 pcs |
buffer) | 20 pcs |
Nozzle with filter | 1 pcs |
Tube Stand | 1 pcs |
Ordering Information
Product |
Cat.No. |
Contents |
EZERTM Flu & COVID-19 Antigen Duo |
P211137 |
20 Tests |
Product detail pictures:
Related Product Guide:
We've been convinced that with joint efforts, the enterprise between us will bring us mutual benefits. We are able to assure you product or service quality and aggressive cost for Professional Design Rapid Molecular Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis , The product will supply to all over the world, such as: United States, Argentina, Oman, Our objective is "to supply first step products and best service for our customers, thus we are sure you must have a margin benefit through cooperating with us". If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.
By tobin from Zambia - 2018.12.11 11:26
It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
By Christine from Armenia - 2017.01.28 18:53